Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Differential Activity of Pazopanib and Imatinib Against PDGFRA-Related MPN and AML

Steffen Koschmieder, MD, Mirle Schemionek, PhD, Christian Elling, PhD, Utz Krug, MD, Torsten Kessler, MD, Wolfgang E. Berdel, Carsten Müller-Tidow, MD

Blood (2011) 118 (21): 5153.

https://doi.org/10.1182/blood.V118.21.5153.5153

Published: 2011

Journal Articles

Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease

Christian Elling, Philipp Erben, Christoph Walz, Marie Frickenhaus, Mirle Schemionek, Martin Stehling, Hubert Serve, Nicholas C. P. Cross, Andreas Hochhaus, Wolf-Karsten Hofmann, Wolfgang E. Berdel, Carsten Müller-Tidow, Andreas Reiter, Steffen Koschmieder

Blood (2011) 117 (10): 2935–2943.

https://doi.org/10.1182/blood-2010-05-286757

Published: 2011

Journal Articles

Role of the Spleen In CML: Lessons from an Inducible Transgenic Mouse Model.

Mirle Schemionek, Christian Elling, Linda Kamp, Tilmann Spieker, Wolfgang E. Berdel, Carsten Mueller-Tidow, Steffen Koschmieder

Blood (2010) 116 (21): 3384.

https://doi.org/10.1182/blood.V116.21.3384.3384

Published: 2010

Journal Articles

BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells

Mirle Schemionek, Christian Elling, Ulrich Steidl, Nicole Bäumer, Ashley Hamilton, Tilmann Spieker, Joachim R. Göthert, Martin Stehling, Amy Wagers, Claudia S. Huettner, Daniel G. Tenen, Lara Tickenbrock, Wolfgang E. Berdel, Hubert Serve, Tessa L. Holyoake, Carsten Müller-Tidow, Steffen Koschmieder

Blood (2010) 115 (16): 3185–3195.

https://doi.org/10.1182/blood-2009-04-215376

Published: 2010

Journal Articles

Novel PDGFRA Point Mutations in Hypereosinophilic Syndrome Induce Growth Factor Independence and Leukemia in Vitro and In Vivo.

Christian Elling, Philipp Erben, MD, Christoph Walz, MD, Marie Frickenhaus, Mirle Schemionek, PhD, Martin Stehling, PhD, Hubert Serve, MD, PhD, Nick C.P. Cross, PhD, Wolfgang Berdel, MD, Carsten Mueller-Tidow, MD, Andreas Reiter, MD, Steffen Koschmieder, MD

Blood (2009) 114 (22): 767.

https://doi.org/10.1182/blood.V114.22.767.767

Published: 2009

Journal Articles

Reversible Transplantable Chronic Phase CML-Like Disease in SCLtTA/BCR-ABL Transgenic Mice.

Mirle Schemionek, Jörg Stypmann, MD, Sven Hermann, MD, Christian Elling, Nicole Bäumer, PhD, Tilmann Spieker, MD, Joachim R. Göthert, MD, Martin Stehling, PhD, Claudia S. Huettner, PhD, Michael Schäfers, MD, Daniel G. Tenen, MD, Wolfgang E. Berdel, MD, Tessa L. Holyoake, MD, Carsten Müller-Tidow, MD, Hubert Serve, MD, Steffen Koschmieder, MD

Blood (2007) 110 (11): 1002.

https://doi.org/10.1182/blood.V110.11.1002.1002

Published: 2007

NARROW

Differential Activity of Pazopanib and Imatinib Against PDGFRA-Related MPN and AML

Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease

Role of the Spleen In CML: Lessons from an Inducible Transgenic Mouse Model.

BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells

Novel PDGFRA Point Mutations in Hypereosinophilic Syndrome Induce Growth Factor Independence and Leukemia in Vitro and In Vivo.

Reversible Transplantable Chronic Phase CML-Like Disease in SCLtTA/BCR-ABL Transgenic Mice.

Email alerts

ASH Publications

American Society of Hematology

Differential Activity of Pazopanib and Imatinib Against PDGFRA-Related MPN and AML

Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease

Role of the Spleen In CML: Lessons from an Inducible Transgenic Mouse Model.

BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells

Novel PDGFRA Point Mutations in Hypereosinophilic Syndrome Induce Growth Factor Independence and Leukemia in Vitro and In Vivo.

Reversible Transplantable Chronic Phase CML-Like Disease in SCLtTA/BCR-ABL Transgenic Mice.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only